| 发明名称 |
METHODS FOR TREATING BRAIN INSULIN RESISTANCE |
| 摘要 |
The invention provides methods for treating brain insulin resistance and/or diseases associated therewith in a subject in need thereof. The methods include providing a composition comprising a dual GLP-1 receptor/GIP receptor (GLP-1R/GIPR) agonist and administering an effective amount of the composition to the subject to treat brain insulin resistance and diseases associated therewith. |
| 申请公布号 |
US2017112897(A1) |
申请公布日期 |
2017.04.27 |
| 申请号 |
US201615332880 |
申请日期 |
2016.10.24 |
| 申请人 |
Cedars-Sinai Medical Center ;Research Foundation of The City University of New York |
发明人 |
Talbot Konrad;Wang Hoau-Yan;Black Keith L. |
| 分类号 |
A61K38/16;A61K31/13;A61K45/06 |
主分类号 |
A61K38/16 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method for treating, inhibiting, reducing the severity of and/or reducing progression of a disease-state in a subject in need thereof comprising:
(i) providing a dual incretin receptor agonist (IRA); and (ii) administering a therapeutically effective amount of the composition to the subject so as to treat the disease-state in the subject. |
| 地址 |
Los Angeles CA US |
